Calithera Biosciences Balance Sheet Health
Financial Health criteria checks 4/6
Calithera Biosciences has a total shareholder equity of $20.4M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $28.7M and $8.3M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
Interest coverage ratio | n/a |
Cash | US$25.45m |
Equity | US$20.39m |
Total liabilities | US$8.28m |
Total assets | US$28.68m |
Recent financial health updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 2CB0's short term assets ($26.6M) exceed its short term liabilities ($7.4M).
Long Term Liabilities: 2CB0's short term assets ($26.6M) exceed its long term liabilities ($894.0K).
Debt to Equity History and Analysis
Debt Level: 2CB0 is debt free.
Reducing Debt: 2CB0 has not had any debt for past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 2CB0 has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: 2CB0 has less than a year of cash runway if free cash flow continues to reduce at historical rates of 18.9% each year